- Nonclinical mouse surrogate data showed reversal of cardiac glycogen accumulation in PRKAG2 syndrome.
- Reinforces scientific rationale for lead investigational therapy ATR 1072.
- Initial Phase 1/2 proof-of-concept clinical data expected in H2 2027.
?? Positive AI Sentiment (+2.5 / 10)